On Target: Enhancing Immunotherapies

DDN white logo2
October 20, 2020 2:30 pm EST

Register for the Webinar

Already registered?
Access the webinar here »

A plethora of immunotherapies, including immune checkpoint inhibitors, T-cell therapy, monoclonal antibodies, and immune system modulators, have been developed in the past several decades to treat growing global incidences of cancer. However, these therapies are not without risk. This webinar will highlight innovative immunotherapeutic strategies using genetic engineering approaches that modify a patient's own immune cells to more precisely target cancers, while concurrently minimizing the risk of adverse responses.

Speaker Information:


Chris DeRenzo, MD, MBA

Department of Bone Marrow Transplantation and Cellular Therapy
St. Jude Children’s Research Hospital

smatosev (1)

Sandro Matosevic, PhD

Assistant Professor, Industrial and Physical Pharmacy
Purdue University


Interested in sponsoring a webinar?
Click here to contact our friendly sales team.

Webinar Sponsor

Horizon-Logo-LR (1)  2019-bio-techne-logo